565 related articles for article (PubMed ID: 28749739)
1. Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.
Lembo D; Donalisio M; Civra A; Argenziano M; Cavalli R
Expert Opin Drug Deliv; 2018 Jan; 15(1):93-114. PubMed ID: 28749739
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticulate delivery systems for antiviral drugs.
Lembo D; Cavalli R
Antivir Chem Chemother; 2010; 21(2):53-70. PubMed ID: 21107015
[TBL] [Abstract][Full Text] [Related]
3. Drug Nanocrystals: A Delivery Channel for Antiviral Therapies.
Chaturvedi A; Sharma S; Shukla R
AAPS PharmSciTech; 2024 Feb; 25(3):41. PubMed ID: 38366178
[TBL] [Abstract][Full Text] [Related]
4. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.
Leone F; Cavalli R
Expert Opin Drug Deliv; 2015; 12(10):1607-25. PubMed ID: 25960000
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicines for treatment of viral diseases.
Mehendale R; Joshi M; Patravale VB
Crit Rev Ther Drug Carrier Syst; 2013; 30(1):1-49. PubMed ID: 23510109
[TBL] [Abstract][Full Text] [Related]
6. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
Hock SC; Ying YM; Wah CL
PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections.
Sánchez A; Mejía SP; Orozco J
Molecules; 2020 Aug; 25(16):. PubMed ID: 32824757
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity.
Cooper DL; Conder CM; Harirforoosh S
Expert Opin Drug Deliv; 2014 Oct; 11(10):1661-80. PubMed ID: 25054316
[TBL] [Abstract][Full Text] [Related]
10. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
[TBL] [Abstract][Full Text] [Related]
11. Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy.
Megantara S; Rusdin A; Budiman A; Shamsuddin S; Mohtar N; Muchtaridi M
Int J Nanomedicine; 2024; 19():2889-2915. PubMed ID: 38525012
[TBL] [Abstract][Full Text] [Related]
12. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
Bhattacharjee S; Brayden DJ
Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
[TBL] [Abstract][Full Text] [Related]
13. Recent Advancement in Nanotechnology-Based Drug Delivery System Against Viral Infections.
Pradhan D; Biswasroy P; Goyal A; Ghosh G; Rath G
AAPS PharmSciTech; 2021 Jan; 22(1):47. PubMed ID: 33447909
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
15. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
Pattnaik S; Pathak K
Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
Muankaew C; Loftsson T
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicines for kidney diseases.
Williams RM; Jaimes EA; Heller DA
Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
20. Development of nanoparticle-delivery systems for antiviral agents: A review.
Delshadi R; Bahrami A; McClements DJ; Moore MD; Williams L
J Control Release; 2021 Mar; 331():30-44. PubMed ID: 33450319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
